Synta Pharmaceuticals Corp (SNTA.OQ)

SNTA.OQ on NASDAQ Stock Exchange Global Market

6.69USD
1 Aug 2013
Price Change (% chg)

$-0.02 (-0.30%)
Prev Close
$6.71
Open
$6.64
Day's High
$6.90
Day's Low
$6.41
Volume
66,222
Avg. Vol
461,196
52-wk High
$11.77
52-wk Low
$3.77

SNTA.OQ

Chart for SNTA.OQ

About

Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. As of December 31, 2011, it had two drug candidates in clinical trials for treating... (more)

Overall

Beta: 2.64
Market Cap (Mil.): $463.89
Shares Outstanding (Mil.): 69.13
Dividend: --
Yield (%): --

Financials

  SNTA.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -1.09 -- --
ROI: -112.85 -2.58 18.76
ROE: -151.52 -2.66 19.59
Search Stocks

Synta Pharma shares soar after co says to expand breast cancer study

- Synta Pharmaceuticals Corp shares soared as much as 47 percent in heavy trading after the company said preliminary results from a mid-stage study of its drug ganetespib in breast cancer patients supported an expansion of the study.

29 Jul 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: Wright Reports
$460.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks